ADIAL PHARMACEUTICALS INC (ADIL) Stock Cash Flow
NASDAQ:ADIL - Nasdaq - US00688A2050 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -8.95M | -13.20M | -7.00M | -12.73M | -19.42M | |||
| Depreciation Amortization | 600.00 | 600.00 | 600.00 | 10.00K | 10.00K | |||
| Income Taxes - Deferred | N/A | N/A | N/A | 0.00 | -90.00K | |||
| Change In Working Capital | 809.70K | 386.10K | -794.20K | -1.37M | 1.47M | |||
| Interest Paid | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Taxes Paid | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | 1.26M | 5.89M | 988.70K | 2.90M | 6.09M | |||
| OPERATING CASH FLOW | -6.88M | -6.92M | -6.81M | -11.19M | -11.95M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | N/A | 0.00 | -60.00K | |||
| Other Investing Activity | N/A | N/A | 1.50M | 0.00 | 30.00K | |||
| INVESTING CASH FLOW | N/A | N/A | 1.50M | 0.00 | -30.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 4.07M | 7.85M | 4.13M | 9.13M | 13.64M | |||
| FINANCING CASH FLOW | 4.07M | 7.85M | 4.13M | 9.13M | 13.64M | |||
| CHANGE IN CASH | -2.66M | 923.40K | -1.17M | -2.06M | 1.66M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -6.88M | -6.92M | -6.81M | -11.19M | -11.95M | |||
| Capital Expenditure | N/A | N/A | N/A | 0.00 | -60.00K | |||
| FREE CASH FLOW | -6.88M | -6.92M | -6.81M | -11.19M | -12.01M | |||
All data in USD